WWM
VRTX icon

Wolff Wiese Magana’s Vertex Pharmaceuticals VRTX Stock Holding History

Wolff Wiese Magana’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.2K Hold
89
– – 0.02% 252
2026
Q1 		$39.7K Hold
89
– – 0.02% 237
2025
Q4 		$40.4K Hold
89
– – 0.02% 229
2025
Q3 		$34.9K Hold
89
– – 0.02% 248
2025
Q2 		$39.6K Sell
89
-42
-32% -$19.4K 0.02% 226
2025
Q1 		$63.5K Sell
131
-20
-13% -$9.32K 0.04% 170
2024
Q4 		$60.8K Sell
151
-5
-3% -$2.32K 0.04% 179
2024
Q3 		$72.6K Buy
156
+112
+255% +$53.8K 0.05% 159
2024
Q2 		$20.6K Sell
44
-25
-36% -$10.9K 0.02% 234
2024
Q1 		$28.8K Sell
69
-15
-18% -$6.34K 0.02% 191
2023
Q4 		$34.2K Sell
84
-5
-6% -$1.85K 0.03% 175
2023
Q3 		$30.9K Sell
89
-2
-2% -$699 0.03% 230
2023
Q2 		$32K Sell
91
-17
-16% -$5.73K 0.02% 234
2023
Q1 		$34K Sell
108
-2
-2% -$600 0.03% 220
2022
Q4 		$31.8K Sell
110
-770
-88% -$235K 0.03% 223
2022
Q3 		$255K Buy
880
+49
+6% +$14.1K 0.2% 89
2022
Q2 		$234K Sell
831
-4,634
-85% -$1.24M 0.17% 100
2022
Q1 		$1.43M Sell
5,465
-143
-3% -$33.9K 0.96% 31
2021
Q4 		$1.23M Sell
5,608
-53
-0.9% -$10.3K 0.79% 38
2021
Q3 		$1.03M Sell
5,661
-3,351
-37% -$654K 0.72% 42
2021
Q2 		$1.82M Buy
9,012
+165
+2% +$34.5K 1.3% 17
2021
Q1 		$1.9M Buy
8,847
+2,396
+37% +$526K 1.49% 15
2020
Q4 		$1.52M Buy
+6,451
New +$1.48M 1.29% 18

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Wolff Wiese Magana's VRTX Position: Q2 2026 in Review

Wolff Wiese Magana held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 89 shares worth $44.2K. The position accounts for 0.02% of the portfolio, ranked #252.

Wolff Wiese Magana first reported a position in VRTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.9M in Q1 2021. 299 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Wolff Wiese Magana held 89 shares of Vertex Pharmaceuticals worth $44.2K as of Q2 2026.
  • Wolff Wiese Magana left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.02% of Wolff Wiese Magana's portfolio in Q2 2026, its #252 holding.
  • Wolff Wiese Magana first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Wolff Wiese Magana's Vertex Pharmaceuticals position peaked at $1.9M in Q1 2021.
  • 299 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.